Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 5, 2006 - Issue 2
Submit an article Journal homepage
36
Views
7
CrossRef citations to date
0
Altmetric
Meeting Highlights

Cardiac safety strategies

25 – 26 October 2005, the Radisson SAS Hotel, Nice, France

Gilles Hanton Associate Research Fellow, Pfizer Global Research and Development, Z.I. Pocé-sur-Cisse, BP 159, F-37401 Amboise Cedex, France. [email protected]
&
Lorraine Tilbury Associate Research Fellow, Pfizer Global Research and Development, Z.I. Pocé-sur-Cisse, BP 159, F-37401 Amboise Cedex, France
Pages 329-333 | Published online: 27 Feb 2006

Bibliography

  • SHAH RR: Drugs, QTc interval prolongation and final ICH E14 guideline. An important milestone with challenges ahead. Drug Safety (2005) 28(11):1009-1028.
  • CAVERO I, CRUMB W: ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis. Expert Opin. Drug Saf. (2005) 4(3):509-530.
  • BELARDINELLI L, ANTZELEVITCH C, VOS MA: Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol. Sci. (2003) 24(12):619-625.
  • HONDEGHEM LM, HOFFMANN P: Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: Importance of triangulation, reverse use dependence, and instability. J. Cardiovasc. Pharmacol. (2003) 41(1):14-24.
  • ANTZELEVITCH C, SHIMIZU W: Cellular mechanisms underlying the long QT syndrome. Curr. Opin. Cardiol. (2002) 17:43-51.
  • HONDEGHEM LM, CARLSSON L. DUKER G: Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation (2001) 103(15):2004-2013.
  • YAN G-X, ANTZELEVITCH C: Cellular basis for the normal T wave and the electrocardiogrphic manifestations of the long-QT syndrome. Circulation (1998) 98(18):1928-1936.
  • GALEANO EJ, YOSHIDA A, OHNISHI Y et al.: Comparative usefulness of beat-to-beat QT dispersion and QT interval fluctuations for identifying patients with organic heart disease at risk for ventricular arrhythmias. Circ. J. (2003) 67(2):125-128.
  • MALIK M, BATCHAVAROV VN: Measurement, interpretation and clinical potential of QT dispersion. J. Am. Coll. Cardiol. (2000) 36(6):1749-1766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.